• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Douglas E. Williams - Articles and news items

Biogen Idec logo

Biogen Idec and Sangamo BioSciences announce global collaboration to develop treatments for Hemoglobinopathies

Industry news / 9 January 2014 / Biogen Idec

“Our collaboration with Sangamo is expected to help us expand our capabilities to develop treatments for people with serious, inherited hematologic conditions…”

Biogen Idec logo

US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review

Industry news, News / 19 July 2013 / Biogen Idec

U.S. and EU regulatory authorities have accepted marketing applications…

Biogen Idec logo

Biogen Idec submits application to FDA for approval of PLEGRIDY™ in multiple sclerosis

Industry news, News / 21 May 2013 / Biogen Idec

EMA submission planned in the coming weeks…

Biogen Idec logo

Biogen Idec reports top-line results from Phase 3 trial

Industry news, News / 3 January 2013 / Biogen Idec

EMPOWER trial fails to demonstrate efficacy in primary and key secondary endpoints…

Biogen Idec logo

New AVONEX® dosing innovations for people with Multiple Sclerosis now available in US

Industry news, News / 14 May 2012 / Biogen Idec

Two new dosing innovations designed to help patients receiving once-a-week AVONEX…

Biogen Idec logo

FDA approves AVONEX PEN and dose titration regimen

Industry news, News / 28 February 2012 /

Dosing enhancements may improve treatment experience for patients receiving AVONEX® (interferon beta-1a) for MS…

Biogen Idec logo

Biogen Idec submits application to FDA for approval of oral BG-12 to treat multiple sclerosis

Industry news, News / 28 February 2012 / Biogen Idec

EMA submission anticipated within the coming days…

Biogen Idec logo

Biogen Idec to acquire Stromedix

Industry news, News / 14 February 2012 / Biogen Idec

Biogen Idec and Stromedix, Inc. announced that they have entered into a definitive agreement under which Biogen Idec will acquire Stromedix Inc…

Biogen Idec logo

Biogen Idec researchers identify novel approach for promoting Remyelination

Industry news, News / 3 July 2011 / Biogen Idec

Results from a study that suggest that inhibiting death receptor-6 (DR6) function may represent a novel approach…

Biogen Idec logo

Biogen Idec receives approval in the European Union for AVONEX(R) PEN(TM)

Industry news, News / 7 June 2011 / Biogen Idec

Biogen Idec announced that the European Commission has granted approval to AVONEX PEN…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +